EXTENSION OF WINDOW FOR SUBMISSION OF EXPRESSION OF INTERESTS (EOIS)
Introduction
On the 1st of November 2023, the AUDA-NEPAD through the AMRH initiative announced the launch of the pilot of the continental procedure on evaluation of medicinal products led by its Evaluation of Medicinal Products Technical Committee (EMP-TC) supported by the Good Manufacturing Practices Technical Committee (GMP-TC). This pilot is one of the core interventions by the AUDA NEPAD in supporting the technical operationalisation of the African Medicines Agency (AMA) which aims to build on regional harmonization initiatives to strengthen regulatory systems continent-wideand facilitate regulatory reliance in alignment with internationally acceptable standards.
Following requests from various industry stakeholders, we are thrilled to announce an extension of the window for submission of expressions of interest to participate in our pilot program for listing human medicinal products. This is your chance to showcase your innovative products and make a difference in the world of healthcare.
Timelines
Key timelines for this extension are provided below:
Window opened for submission of Interests (EOIs) - 8 April 2024
Window closed for industry to submit EOIs - 10 May 2024
Window opened for submission of dossiers - To be communicated to successful applicants
More details on how to submit EOIs is as provided in the previous call accessed here:
Contacts
For all technical related matters contact: amrh@nepad.org copy to: emp@nepad.org
For general enquiries and submissions communication: AUDAPilot@sahpra.org.za